Frontlight ResearchEarly access
Trial site
Toeroekbalinti Tuedogyogyintezet
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Lead sponsor
- AstraZeneca2 trials
- AstraZeneca AB1 trial
- Daiichi Sankyo1 trial
- F. Hoffmann-La Roche AG1 trial
- GlaxoSmithKline1 trial
- and 1 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Active, not recruiting
Completed
Completed
Phase 3 study of SBRT ± pembrolizumab for participants with unresectable Stage I or II NSCLC
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026